We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment.
- Authors
Helbo, Thomas; Boel, Jonas Bredtoft; Bartels, Mette Damkjær; Ahlström, Magnus Glindvad; Holzknecht, Barbara Juliane; Eriksen, Helle Brander
- Abstract
Background Decolonization treatment of MRSA carriers is recommended in Denmark, except in households with MRSA-positive children <2 years old (wait-and-see approach). Objectives To investigate a wait-and-see approach in children 2–5 years old, and the effect of decolonization treatment of MRSA carriage in all children <6 years old. Patients and methods In this retrospective follow-up study, we included MRSA carriers <6 years old in the Capital Region of Denmark from 2007 to 2021. Data were collected from laboratory information systems and electronic patient records. We divided children into age groups of <2 years or 2–5 years and decolonization treatment versus no treatment. Treatment was chlorhexidine body washes and nasal mupirocin, sometimes supplemented with systemic antibiotics. Children were followed until becoming MRSA free, or censoring. The probability of becoming MRSA free was investigated with Cox regression (higher HRs indicate faster decolonization). Results Of 348 included children, 226 were <2 years old [56/226 (25%) received treatment] and 122 were 2–5 years old [90/122 (74%) received treatment]. Multivariable analyses did not show a larger effect of decolonization treatment versus no treatment in <2-year-olds (HR 0.92, 95% CI 0.52–1.65) or 2–5-year-olds (HR 0.54, 95% CI 0.26–1.12). Without treatment, 2–5-year-olds tended to clear MRSA faster than <2-year-olds (HR 1.81, 95% CI 0.98–3.37). Conclusions We did not find a larger effect of decolonization treatment versus no treatment in children <6 years old, and 2–5-year-olds tended to become MRSA free faster than <2-year-olds. These results support a wait-and-see approach for all children <6 years old, but further studies are needed.
- Subjects
DENMARK; METHICILLIN-resistant staphylococcus aureus; MUPIROCIN; AGE groups; ELECTRONIC systems; CURRICULUM; ELECTRONIC records
- Publication
Journal of Antimicrobial Chemotherapy (JAC), 2024, Vol 79, Issue 4, p826
- ISSN
0305-7453
- Publication type
Article
- DOI
10.1093/jac/dkae036